Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 20;2(1):6.
doi: 10.1186/2045-4015-2-6.

Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

Gary M Ginsberg  1 , Arthur I Eidelman, Eric Shinwell, Emilia Anis, Reuven Peyser, Yoram Lotan
Affiliations

Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

Gary M Ginsberg et al. Isr J Health Policy Res. .

Abstract

Background: In Israel, an average of 37 children are born each year with sepsis and another four with meningitis as a result of Group B Streptococcal (GBS) disease. Israel currently only screens mothers with defined risk factors (around 15% of all pregnancies) in order to identify candidates for Intrapartum Antiobiotic Prophyhlaxis (IAP) of GBS. This paper presents a cost-utility analysis of implementing an alternative strategy, which would expand the current protocol to one aiming to screen all pregnant women at 35-37 weeks gestation based on taking a vaginal culture for GBS.

Methods: A spreadsheet model was built incorporating technical, epidemiological, health service costs, demographic and economic data based primarily on Israeli sources.

Results: The intervention of universal screening (compared with the current scenario) would increase screening costs from 580,000 NIS to 3,278,000 million NIS. In addition, the intervention would also increase penicillin costs from 39,000 NIS to 221,000 NIS. Current culture screening of approximately 15% of mothers-to-be with high risk factors resulted in 42 GBS births in 2008-9 (0.253/1000 births). Expanding culture screening to 85% of mothers-to-be, will decrease the number of GBS births to 17.3 (0.104/1000 births). The initial 2.9 million NIS incremental intervention costs are offset by decreased treatment costs of 1.9 million NIS and work productivity gains of 811,000 NIS as a result of a decrease in neurological sequelae from GBS caused meningitis. Thus the resultant net cost of the intervention is only around 134,000 NIS. Culture based screening will reduce the burden of disease by 12.6 discounted Quality Adjusted Life Years (QALYS), giving a very cost effective baseline incremental cost per QALY (cf. risk factor screening) of 10,641 NIS per QALY. The data was very sensitive to rates of anaphylactic shock and changes in the percentage of meningitis cases that had associated long term-sequelae.

Conclusion: It is recommended that Israel adopt universal culture-based GBS screening.

PubMed Disclaimer

References

    1. German L, Solt I, Bornstein J, Ben-Harush S, Ben-Elishai M, Weintraub Z. Is there an increase in the incidence of gbs carrier rates among pregnant women in northern Israel? Harefuah. 2006;145(12):866–9. 944. [Article in Hebrew] - PubMed
    1. Eisenberg VH, Raveh D, Meislish Y, Rudensky B, Ezra Y, Samueloff A, Eidelman AI, Schimmel MS. Prevention of early-onset neonatal group B streptococcal infection: is universal screening by culture universally applicable? Isr Med Assoc J. 2006;10:698–702. - PubMed
    1. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR. 2010;59:RR–10. 1-25. - PubMed
    1. Ezra Y. Israel perinatal statistics. Sheraton City Towers, Ramat Gan, Israel: Israel Society Maternal -Fetal Medicine; 2008.
    1. Ministry of Health. Health in Israel, selected data 2010. Jerusalem: Health Information Department, Ministry of Health; 2010.

LinkOut - more resources